.png)
Premium Ingredients
clinical dosages in every serving
Made in the USA
Following Certified Good Manufacturing Process Standards
GMO FREE
100% Natural Based Ingredients
VitaBreastCancer
THC + CBD + CBG + CBC
Please read the complete product data sheet carefully before using VitaBreastCancer, as it contains essential information for your health. If you have any questions, consult your doctor. If you experience side effects, even those not listed in this document, consult your doctor immediately.
-
What is breast cancer? Recognize the Symptoms
-
What is VitaBreastCancer?
-
Why VitaBreastCancer?
-
Important Information Before Using VitaBreastCancer
-
How to Take VitaBreastCancer
-
Possible Side Effects
-
Storing VitaBreastCancer
-
Package Contents and Additional Information
-
Disclaimer
1. What is Breast Cancer? Learn to identify the symptoms
Breast cancer is a disease that begins in the cells of the breast, most commonly in the milk ducts (which carry milk to the nipple) or the lobules (the glands that produce milk). While primarily affecting women, men can also develop breast cancer, though it is much rarer.
Early detection is crucial for successful treatment, as it significantly improves the chances of recovery. Recognizing the warning signs and understanding the risk factors that increase susceptibility to breast cancer are key steps in prevention and early intervention. When breast cancer is detected at an early stage, treatment options are more effective, and outcomes are generally more favorable.
Breast cancer can manifest with a range of signs and symptoms, which may differ from person to person. Common symptoms include:
-
Lump or thickening in the breast or underarm: A new lump or mass is the most common symptom of breast cancer. While some lumps may be painless, others could be tender or painful to the touch.
-
Change in breast size or shape: Any unexplained changes in the size, shape, or appearance of one or both breasts should be monitored closely.
-
Nipple discharge: Any unusual discharge from the nipple, especially if it is bloody or clear, should be reported to a healthcare professional.
-
Nipple retraction or inversion: If the nipple starts to turn inward or flatten, it could be a sign of an underlying issue, including breast cancer.
-
Skin changes: Dimpling, puckering, or redness of the skin on the breast, resembling the texture of an orange peel, can indicate breast cancer.
-
Breast or nipple pain: While breast pain is not typically a common early symptom of cancer, persistent pain in the breast or nipple area should be evaluated.
-
Swelling or enlargement: Unexplained swelling or changes in the contour of the breast, especially if it affects only one side, may signal abnormal growth.
-
Skin irritation or rash: Any persistent irritation, rash, or ulceration on the breast or nipple area could be a warning sign.
Several risk factors can increase the likelihood of developing breast cancer. Age is a significant factor, with the risk rising particularly after the age of 50. A family history of breast cancer, especially in close relatives like a mother or sister, also heightens the risk. Inherited genetic mutations, such as those in the BRCA1 and BRCA2 genes, further elevate the likelihood of developing the disease. Hormonal factors, including early menstruation, late menopause, and hormone replacement therapy, can influence breast cancer risk as well. Additionally, lifestyle choices such as lack of physical activity, a diet high in saturated fats, smoking, and excessive alcohol consumption have been linked to an increased risk of breast cancer.
2. What is VitaBreastCancer?
VitaBreastCancer is a cutting-edge formulation developed to treat breast cancer, especially in early stages, by integrating phytocannabinoids into advanced nanoplatform technology. This innovative approach is designed to precisely target breast cancer cells, inhibiting tumor growth by modulating key molecular pathways involved in cancer progression. The formulation harnesses the therapeutic potential of cannabinoids such as CBD (cannabidiol), THC (tetrahydrocannabinol), CBG (cannabigerol), and CBC (cannabichromene), all of which have shown promising anti-cancer properties in preclinical studies, including reducing tumor size, inhibiting angiogenesis and metastasis, and inducing cancer cell apoptosis.
What sets VitaBreastCancer apart is its use of nanoplatform technology, which enhances the bioavailability and targeted delivery of these cannabinoids directly to tumor sites. Nanoplatforms allow for controlled and sustained release of active compounds, improving the penetration into cancerous tissues while minimizing the impact on healthy cells. This precision not only boosts the efficacy of the treatment but also reduces the potential for side effects often associated with traditional chemotherapy and radiation therapies.
Furthermore, by incorporating phytocannabinoids, VitaBreastCancer complements conventional breast cancer treatments such as chemotherapy, radiation, and hormone therapy. The cannabinoids work in synergy with these treatments, enhancing their effectiveness by sensitizing cancer cells to treatment and reducing inflammation, oxidative stress, and pain commonly experienced during cancer therapy.
This multi-targeted approach makes VitaBreastCancer a promising option in the fight against breast cancer, aiming to improve patient outcomes and quality of life during treatment.
.png)
3. Why VitaBreastCancer?
VitaBreastCancer presents a novel, targeted approach to breast cancer treatment by utilizing a combination of phytocannabinoids: THC (tetrahydrocannabinol), CBD (cannabidiol), CBG (cannabigerol), and CBC (cannabichromene), formulated within advanced nanoplatform technology. This formulation offers multiple therapeutic benefits aimed at counteracting breast cancer progression through inhibition of tumor growth and angiogenesis, prevention of metastasis, and modulation of critical molecular pathways. Given its unique composition and mechanism of action, VitaBreastCancer stands out as a highly promising addition to current breast cancer therapies.
VitaBreastCancer is designed for patients diagnosed with breast cancer subtypes such as HER2-positive (HER2+), estrogen receptor-positive (ER+), progesterone receptor-positive (PR+), and triple-negative breast cancer (TNBC), particularly in stages I and II of the disease.
The phytocannabinoid formulation works by inhibiting vascular endothelial growth factor (VEGF), a key promoter of tumor angiogenesis, thereby restricting blood supply to the tumor and inducing apoptosis (programmed cell death) in cancer cells. This dual mechanism of action is particularly effective in preventing tumor growth and recurrence, two critical challenges in breast cancer management. The method also aims to reduce tumor size, slow disease progression, and improve patient outcomes through a tailored regimen that optimizes therapeutic efficacy while minimizing side effects.
VitaBreastCancer also allows for the customization of treatment regimens, including variations in dosing schedules, combinations with other therapies, and real-time adjustments based on the patient’s response. This adaptable treatment approach ensures that patients receive personalized care tailored to their unique cancer characteristics, intending to achieve complete disease remission, minimize recurrence, and improve long-term survival outcomes.
This product offers a therapeutic option for aggressive and treatment-resistant forms of breast cancer, improving outcomes through a dosage regimen tailored to the specific molecular characteristics of the tumors. With its comprehensive and targeted approach, VitaBreastCancer represents a promising advancement in the management of breast cancer, offering new hope for patients with challenging diagnosis.
4. Important Information Before Using VitaBreastCancer
Consult your doctor if:
-
You are taking other medications, especially those metabolized by the liver (e.g., anticoagulants, antiepileptics, antidepressants).
-
You are pregnant or breastfeeding, as the safety of THC, CBD, CBG, and CBC, during these periods is not fully established. Therefore, it is recommended to avoid use in these periods unless indicated by a physician on a risk-benefit basis.
-
You have pre-existing medical conditions, such as liver, kidney, or cardiovascular diseases.
Do not take VitaBreastCancer if:
-
If you are allergic to cannabinoids or any of the other components of this product.
-
If you are taking beta-blocker drugs such as metoprolol as it may potentiate the mechanism of action of the drug inducing hypotension, dizziness, weakness.
5. How to take VitaBreastCancer
-
Follow your doctor's instructions and the product label for dosage.
-
Swallow the capsule whole with water.
-
Do not exceed the recommended dosage.
The recommended dosage in adults is: 1 - 2 capsules daily for 12 weeks.
If you accidentally take more than the recommended dose, seek medical help immediately. Symptoms of overdose include nausea, vomiting, seizures, heart problems (such as irregular heartbeat or cardiac arrest), lung conditions, and altered mental status.
Recommendations:
-
If you miss a dose, don’t worry. Simply take your next dose at the regular scheduled time the following day. Avoid doubling up on doses to make up for the missed one.
-
To help you remember, try to take VitaBreastCancer at the same time each day.
-
Do not discontinue VitaBreastCancer without consulting your doctor, even if you begin to feel better. Consistent use is important for maintaining its therapeutic effects.
-
If you have any questions or concerns about how to use this product, consult your doctor.
6. Possible side effects
-
If you experience a skin rash or any allergic reactions such as itching, swelling of the lips or tongue, wheezing, or difficulty breathing, stop using the product immediately and seek medical advice as soon as possible.
-
Common side effects (affecting more than 1 in 10 people) may include insomnia, headaches, diarrhea, nausea, and fatigue.
-
Rare side effects may include elevated liver enzymes (AST, ALT, GGT), seizures, status epilepticus, gait disturbances, or abnormal behavior.
Reporting of adverse effects:
If you experience any type of adverse effect, consult your doctor, even if it is a possible adverse effect not listed in this datasheet. You can also communicate directly via email.
By reporting adverse effects you can contribute to providing more information about the safety of this product.
7. Storage of VitaShingles Product
-
Keep this product out of the sight and reach of children.
-
Do not use this product after the expiration date stated on the package. The expiration date is the last day of the month indicated.
-
Store VitaMenopuase softgels at a temperature below 30 ºC.
8. Package contents and additional information
VitaBreastCancer Softgels
The active ingredients are Cannabidiol (CBD), Cannabigerol (CBG), Cannabichromene (CBC), and Tetrahidrocannabinol (THC). Each softgel capsule contains 35 milligrams (mg) of CBD, 30 milligrams (mg) of CBG, 30 milligrams (mg) of CBN, and 5 milligrams (mg) of THC.
The other ingredients are: Medium chain triglycerides (MCT), Sorbitan 80 (Span 80) Vitamin E, Polysorbate 80 (Tween 80) and Polyethylene glycol 400.
Appearance of the product and package contents
The soft capsule is oval-shaped with a smooth, shiny surface and amber color.
The capsules are available in packs of 30, 60 and 90 capsules.
9. Disclaimer
The information provided here is based on extensive research conducted to develop VitaBreastCancer and its proposed mechanisms of action. However, this information is intended for informational purposes only and does not constitute medical advice.
These statements and products have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
.png)